Ziprasidone in the treatment of affective disorders: a review. (Q37336886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Ziprasidone in the treatment of affective disorders: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Carla Torrent

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Eduard Vieta

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Carolina Franco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mercè Comes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Nuria Cruz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Guillermo Horga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Antonio Benabarre

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

278-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder

17 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00056.X

Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.

21 January 2018

1 reference

12 December 2020

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients

1 reference

12 December 2020

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

1 reference

12 December 2020

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

1 reference

12 December 2020

Ziprasidone: the fifth atypical antipsychotic

1 reference

12 December 2020

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

1 reference

12 December 2020

Ziprasidone-associated mania: a case series and review of the mechanism

1 reference

12 December 2020

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

1 reference

12 December 2020

Case for caution, case for action.

1 reference

12 December 2020

Ziprasidone-related tardive dyskinesia

1 reference

12 December 2020

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

1 reference

12 December 2020

The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy

1 reference

12 December 2020

Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.

1 reference

12 December 2020

Ziprasidone-associated mania: a review and report of 2 additional cases

1 reference

12 December 2020

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

1 reference

12 December 2020

Pharmacokinetics and therapeutics of acute intramuscular ziprasidone

1 reference

12 December 2020

Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam

1 reference

12 December 2020

From clinical research to clinical practice: a 4-year review of ziprasidone

1 reference

12 December 2020

Extrapyramidal side effects with atypical neuroleptics in bipolar disorder

1 reference

12 December 2020

Sudden akathisia after a ziprasidone dose reduction

1 reference

12 December 2020

Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder

1 reference

12 December 2020

Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.

1 reference

12 December 2020

Ziprasidone: efficacy and safety in patients with bipolar disorder

1 reference

12 December 2020

Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.

1 reference

12 December 2020

Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study

1 reference

12 December 2020

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study

1 reference

12 December 2020

10.1111/J.1755-5949.2008.00056.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19040553%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

19040553

1 reference